688073.SS · 毕得医药
China A-shares · RS rating 92 · As of 2026-10-14
| Price | 62.86 CNY |
|---|---|
| 1-day change | -4.6% |
| RS rating (overall / 1M / 3M / 12M) | 92 / 90 / 92 / 50 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 44 / 35 / 28 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +11.2% |
| Distance from 52-week high | +25.9% |
| Market cap (USD) | $962.3M |